Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
FHTX	FOGHORN THERAPEUTICS INC	$242.47M	N/A	-29.50%	-39.92%	-44.90%	-7.24	3.73	100.00%	-383.20%	-383.24%
ZLAB	ZAI LAB LTD	$3.46B	-34.60%	-24.80%	-28.75%	-164.20%	0.41	3.51	62.90%	-64.40%	-63.87%
LXRX	LEXICON PHARMACEUTICALS INC	$255.94M	-93.90%	-56.80%	-73.00%	-58.20%	1.05	5.44	98.00%	-644.80%	-594.65%
CVAC	CUREVAC NV	$724.61M	28.90%	22.30%	26.24%	78.80%	0.15	7.28	80.20%	30.30%	35.82%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	N/A	N/A	N/A	169.54%	N/A	-1.62	0.25	100.00%	-14,335.50%	-11,254.71%
PTGX	PROTAGONIST THERAPEUTICS INC	$2.73B	47.70%	42.50%	40.07%	65.90%	0.10	12.48	100.00%	63.30%	64.32%
XCUR	EXICURE INC	$68.23M	-319.70%	-82.40%	-80.73%	-88.70%	1.22	4.45	100.00%	-1,940.20%	-1,935.00%
VALN	VALNEVA SE	$570.83M	-6.50%	-2.50%	3.24%	3.00%	1.76	2.61	41.90%	-7.20%	7.37%
AXSM	AXSOME THERAPEUTICS INC	$5.18B	-289.50%	-51.70%	-82.91%	-161.80%	8.97	2.11	91.40%	-74.50%	-72.74%
TCRX	TSCAN THERAPEUTICS INC	$90.55M	-60.10%	-38.20%	-36.95%	-57.90%	0.54	8.14	100.00%	-4,527.70%	-4,397.94%
XLO	XILIO THERAPEUTICS INC	$42.92M	-238.30%	-73.20%	-132.93%	1,397.00%	3.04	2.21	100.00%	-918.00%	-918.05%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$60.18M	-1,195.80%	-43.50%	-33.13%	-53.40%	0.12	15.40	100.00%	-26,045.00%	-26,045.02%
SEER	SEER INC	$117.77M	-24.40%	-21.90%	-24.63%	-23.70%	0.12	16.53	49.80%	-611.10%	-610.45%
ALEC	ALECTOR INC	$112.96M	-82.80%	-21.70%	-34.65%	-30.40%	2.69	3.40	100.00%	-118.40%	-118.26%
LENZ	LENZ THERAPEUTICS INC	$740.08M	-24.60%	-23.20%	-24.29%	-42.30%	0.06	20.37	N/A	N/A	N/A
MDCX	MEDICUS PHARMA LTD	$52.99M	-357.90%	-211.10%	-334.69%	1,263.90%	0.80	2.33	N/A	N/A	N/A
ATYR	ATYR PHARMA INC	$297.68M	-85.00%	-62.80%	-78.21%	-71.60%	0.39	5.48	100.00%	-27,243.80%	-27,243.83%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	N/A	N/A	-91.30%	35.77%	44.70%	-1.47	0.30	35.70%	-1,412.10%	-1,317.46%
MDWD	MEDIWOUND LTD	$195.14M	-113.60%	-45.10%	-36.95%	-68.00%	1.36	1.97	13.00%	-149.50%	-85.81%
VRNA	VERONA PHARMA PLC	$5.56B	-95.20%	-43.90%	-32.34%	-72.30%	1.32	10.63	93.90%	-410.20%	-330.16%
RLAY	RELAY THERAPEUTICS INC	$542.47M	-44.40%	-39.60%	-41.16%	-47.30%	0.12	15.95	100.00%	-3,374.70%	-3,374.72%
ZYME	ZYMEWORKS INC	$874.58M	-31.70%	-24.30%	-31.11%	-34.00%	0.37	3.40	100.00%	-160.80%	-152.82%
TRAW	TRAWS PHARMA INC	$7.86M	N/A	-309.10%	-407.13%	767.90%	-1.79	2.16	100.00%	-24,192.00%	-24,192.04%
XNCR	XENCOR INC	$740.55M	-36.10%	-25.50%	-22.48%	-21.60%	0.41	6.61	100.00%	-210.50%	-175.90%
IMTX	IMMATICS NV	$549.41M	3.50%	2.40%	3.40%	6.10%	0.21	9.26	100.00%	9.80%	13.70%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$90.09M	-70.40%	-50.40%	-68.26%	-64.00%	0.47	4.92	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$332.34M	16.90%	12.10%	13.66%	16.60%	0.23	11.15	100.00%	31.10%	31.54%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$3.52B	-196.10%	-38.20%	-48.96%	-70.90%	5.00	2.37	86.30%	-101.60%	-101.31%
RYTM	RHYTHM PHARMACEUTICALS INC	$4.03B	-790.50%	-75.80%	-86.59%	-135.40%	10.48	3.24	89.70%	-203.30%	-184.17%
PRME	PRIME MEDICINE INC	$221.66M	-100.10%	-65.20%	-75.47%	-105.50%	0.94	5.58	100.00%	-6,566.60%	-6,566.61%
FTRE	FORTREA HOLDINGS INC	$532.80M	-22.20%	-8.70%	-7.92%	-12.10%	1.63	1.00	19.80%	-12.20%	-7.72%
OABI	OMNIAB INC	$214.96M	-21.10%	-18.40%	-23.00%	-77.70%	0.13	4.52	100.00%	-235.10%	-270.59%
PHIO	PHIO PHARMACEUTICALS CORP	$9.75M	-150.20%	-120.40%	-151.39%	986.50%	0.22	5.65	N/A	N/A	N/A
SION	SIONNA THERAPEUTICS INC	$535.67M	N/A	-51.90%	-35.18%	-76.50%	-0.12	14.49	N/A	N/A	N/A
NEUP	NEUPHORIA THERAPEUTICS INC	$8.86M	-13.40%	-10.10%	-19.98%	307.20%	0.32	2.06	100.00%	-433.30%	-483.45%
ORMP	ORAMED PHARMACEUTICALS INC	$95.18M	-11.80%	-10.80%	-10.04%	-12.20%	0.07	25.19	N/A	N/A	N/A
ANTX	AN2 THERAPEUTICS INC	$37.62M	-54.20%	-48.90%	-62.70%	-75.40%	0.13	8.43	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$17.31B	-83.00%	-60.80%	-53.99%	-73.70%	0.12	10.16	N/A	N/A	N/A
ARVN	ARVINAS INC	$622.39M	-33.70%	-16.70%	-23.02%	-24.50%	0.94	4.64	100.00%	-75.50%	-75.28%
ASMB	ASSEMBLY BIOSCIENCES INC	$80.29M	-126.90%	-35.30%	-55.84%	-84.50%	2.57	2.42	N/A	N/A	N/A
GNLX	GENELUX CORP	$99.66M	-106.60%	-82.50%	-107.39%	-118.70%	0.32	4.57	100.00%	-373,362.50%	-373,362.50%
RADX	RADIOPHARM THERANOSTICS LTD	$26.53M	-105.50%	-52.50%	-50.53%	-174.90%	0.76	3.37	4.00%	-2,427.10%	-2,381.21%
PGEN	PRECIGEN INC	$441.06M	-215.70%	-115.60%	-103.45%	-374.10%	2.04	4.76	-8.70%	-3,216.20%	-3,261.71%
ABVC	ABVC BIOPHARMA INC	$15.42M	-76.40%	-38.40%	-426.23%	-53.00%	5.56	0.33	99.90%	-962.10%	-821.74%
NRSN	NEUROSENSE THERAPEUTICS LTD	$23.23M	N/A	-461.70%	-395.28%	388.00%	0.77	2.21	N/A	N/A	N/A
INSM	INSMED INC	$12.61B	-1,066.20%	-51.90%	-47.76%	-46.40%	6.10	5.45	76.40%	-251.20%	-226.87%
MGNX	MACROGENICS INC	$107.88M	-66.90%	-27.50%	-31.49%	-72.10%	1.26	3.92	91.80%	-44.70%	-43.28%
RAPP	RAPPORT THERAPEUTICS INC	$387.59M	-33.80%	-26.10%	-25.58%	-35.20%	0.03	35.34	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$1.15B	-50.80%	-39.90%	-47.58%	-84.50%	0.28	3.74	24.40%	-226.80%	-228.56%
CYTK	CYTOKINETICS INC	$4.79B	N/A	-45.60%	-45.16%	-30.00%	-11.35	6.17	100.00%	-3,191.10%	-2,987.04%
BPMC	BLUEPRINT MEDICINES CORP	$5.60B	-21.60%	-5.80%	-4.10%	-3.00%	2.95	2.85	96.00%	-13.20%	-7.41%
FATE	FATE THERAPEUTICS INC	$146.68M	-49.50%	-36.60%	-46.31%	-37.60%	0.38	7.58	100.00%	-1,366.50%	-1,366.46%
YMAB	Y-MABS THERAPEUTICS INC	$185.39M	-31.30%	-23.40%	-32.43%	-120.10%	0.30	4.16	82.60%	-33.80%	-35.58%
ERAS	ERASCA INC	$393.74M	-40.10%	-33.60%	-34.31%	-39.50%	0.19	9.84	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$360.80M	-110.60%	-51.50%	-66.50%	-179.50%	1.24	5.42	100.00%	-1,071.60%	-1,070.39%
IPSC	CENTURY THERAPEUTICS INC	$43.19M	-66.90%	-33.60%	-55.84%	-41.70%	1.19	1.50	100.00%	-1,920.90%	-1,893.70%
TARA	PROTARA THERAPEUTICS INC	$158.84M	-44.70%	-40.10%	-26.16%	-229.80%	0.09	15.71	N/A	N/A	N/A
IMCR	IMMUNOCORE HOLDINGS PLC	$1.51B	-14.00%	-5.00%	-4.28%	-4.80%	1.80	4.38	99.10%	-16.50%	-10.99%
CGEN	COMPUGEN LTD	$132.52M	-24.40%	-12.30%	-10.24%	-43.50%	1.09	5.26	71.50%	-51.10%	-34.84%
EVAX	EVAXION BIOTECH A	$2.31M	N/A	-83.30%	-101.42%	-70.50%	-8.56	2.01	100.00%	-316.00%	-246.17%
RNAC	CARTESIAN THERAPEUTICS INC	$306.48M	N/A	-19.80%	-18.72%	-44.40%	-64.96	9.43	100.00%	-199.00%	-198.23%
AVXL	ANAVEX LIFE SCIENCES CORP	$801.30M	-37.50%	-34.10%	-41.99%	529.50%	0.12	9.45	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$35.02M	N/A	-585.50%	136.70%	220.30%	-1.16	0.15	N/A	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$1.10B	-43.30%	-39.50%	-38.43%	-49.40%	0.11	15.43	100.00%	-89,387.10%	-88,378.48%
COYA	COYA THERAPEUTICS INC	$103.36M	-42.70%	-37.90%	-38.50%	-6,359.70%	0.12	11.59	100.00%	-418.70%	-438.96%
SLS	SELLAS LIFE SCIENCES GROUP INC	$127.19M	-325.50%	-144.50%	-311.24%	432.20%	1.05	1.72	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-88.10%	-45.20%	-59.66%	3,668.10%	0.78	1.75	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$2.28B	-31.40%	-28.60%	-33.23%	-31.60%	0.12	8.46	N/A	N/A	N/A
BLTE	BELITE BIO INC	$1.85B	-30.60%	-29.30%	-24.72%	-60.90%	0.04	24.31	N/A	N/A	N/A
PRLD	PRELUDE THERAPEUTICS INC	$49.69M	-74.70%	-60.30%	-84.85%	-69.20%	0.34	5.30	N/A	N/A	N/A
ITRM	ITERUM THERAPEUTICS PLC	$43.57M	N/A	-105.10%	-81.56%	-139.80%	-11.93	1.41	N/A	N/A	N/A
RZLT	REZOLUTE INC	$233.06M	-70.30%	-62.40%	-70.15%	-85.30%	0.13	9.30	N/A	N/A	N/A
SGMO	SANGAMO THERAPEUTICS INC	$176.85M	-275.30%	-90.10%	-175.73%	-184.00%	3.46	1.13	100.00%	-169.40%	-169.74%
IFRX	INFLARX NV	$77.16M	-60.70%	-51.80%	-74.43%	-83.40%	0.24	5.06	-1,900.80%	-27,785.00%	-27,769.42%
ACTU	ACTUATE THERAPEUTICS INC	$174.81M	N/A	-389.60%	-5,284.79%	296.50%	88.44	1.05	N/A	N/A	N/A
TIL	INSTIL BIO INC	$83.40M	-39.70%	-26.10%	-25.48%	-18.60%	0.56	15.76	N/A	N/A	N/A
TECX	TECTONIC THERAPEUTIC INC	$393.60M	-42.50%	-38.20%	-40.96%	1,245.40%	0.09	12.65	N/A	N/A	N/A
PSTV	PLUS THERAPEUTICS INC	$13.40M	N/A	-170.50%	103.77%	150.40%	-1.74	0.34	100.00%	-222.80%	-158.89%
PRTA	PROTHENA CORP PUBLIC LTD CO	$522.12M	-23.20%	-20.30%	-25.86%	-302.50%	0.12	10.01	100.00%	-90.50%	-95.39%
AARD	AARDVARK THERAPEUTICS INC	$172.05M	N/A	-46.80%	-28.37%	-364.40%	-0.10	15.05	N/A	N/A	N/A
ITOS	ITEOS THERAPEUTICS INC	$280.73M	-22.20%	-19.30%	-18.61%	-24.10%	0.16	12.63	100.00%	-384.00%	-343.83%
ALXO	ALX ONCOLOGY HOLDINGS INC	$28.93M	-94.00%	-70.90%	-102.98%	-86.60%	0.30	7.26	N/A	N/A	N/A
JAGX	JAGUAR HEALTH INC	$7.35M	-309.20%	-67.30%	-113.46%	-92.70%	6.10	1.63	83.30%	-329.30%	-327.32%
SWTX	SPRINGWORKS THERAPEUTICS INC	$3.35B	-48.30%	-41.80%	-52.97%	-55.80%	0.22	3.81	93.40%	-134.70%	-134.73%
MCRB	SERES THERAPEUTICS INC	$87.88M	-0.50%	0.10%	0.14%	0.10%	9.14	0.94	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$59.17M	-3,509.90%	-231.80%	-367.65%	670.80%	1.79	2.65	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$1.92B	-49.90%	-43.20%	-31.89%	797.60%	0.14	8.08	100.00%	-530.30%	-530.25%
FBIO	FORTRESS BIOTECH INC	$48.44M	-263.60%	-38.40%	-44.16%	-58.00%	6.42	1.27	63.80%	-96.90%	-55.76%
BCAX	BICARA THERAPEUTICS INC	$792.77M	-39.60%	-18.30%	-13.78%	1,726.90%	0.04	27.93	N/A	N/A	N/A
IMMP	IMMUTEP LTD	$237.26M	-30.50%	-28.70%	-25.32%	-88.10%	0.06	18.86	100.00%	-398.60%	-398.29%
SAVA	CASSAVA SCIENCES INC	$75.84M	-16.80%	-12.50%	-16.70%	140.60%	0.08	11.62	N/A	N/A	N/A
QTTB	Q32 BIO INC	$22.81M	-179.70%	-40.30%	-62.89%	-228.90%	15.27	4.97	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$881.28M	-47.50%	-36.10%	-39.66%	-50.10%	0.28	6.26	100.00%	-369.40%	-369.08%
AVBP	ARRIVENT BIOPHARMA INC	$708.22M	-28.00%	-26.70%	-31.24%	-181.30%	0.07	13.14	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$1.23B	-53.30%	-38.60%	-43.19%	-178.10%	0.45	10.66	91.20%	-303.70%	-282.36%
SXTP	60 DEGREES PHARMACEUTICALS INC	$4.35M	-166.00%	-130.30%	-193.53%	-291.20%	0.45	3.25	43.50%	-1,237.30%	-1,165.19%
WHWK	WHITEHAWK THERAPEUTICS INC	$67.84M	-87.70%	-69.10%	-119.33%	-176.90%	0.34	3.59	88.40%	-245.10%	-244.53%
UNCY	UNICYCIVE THERAPEUTICS INC	$76.61M	N/A	-90.40%	-485.67%	257.30%	3.26	1.28	N/A	N/A	N/A
MGX	METAGENOMI INC	$65.05M	-30.10%	-21.00%	-29.09%	-27.20%	0.38	6.91	100.00%	-149.30%	-159.81%
IMNM	IMMUNOME INC	$730.39M	-125.30%	-105.30%	-157.56%	-520.50%	0.33	4.08	100.00%	-3,240.40%	-3,240.38%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 141.53% over the past year, overperforming other biotech stocks by 220 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 426.32% from Protalix Biotherapeutics's current stock price of $2.85.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 67.97% over the past year, overperforming other biotech stocks by 146 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.74% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 41.58% from Catalyst Pharmaceuticals's current stock price of $23.45.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.68%, which is 5 percentage points higher than the biotech industry average of 1.9%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.6%, which is 1 percentage points higher than the biotech industry average of 1.9%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.34%, which is -1 percentage points lower than the biotech industry average of 1.9%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.65% in the last day, and up 6% over the last week. Intensity Therapeutics was the among the top losers in the biotechnology industry, dropping -37.11% yesterday.

Intensity Therapeutics shares are trading lower after the company announced a $2.35 million public offering.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 2.35% in the past year. It has overperformed other stocks in the biotech industry by 80 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -38.52% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 3.14% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

Are biotech stocks a good buy now?

55.47% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 108.65% over the next year.

1.53% of biotech stocks have a Zen Rating of A (Strong Buy), 5.03% of biotech stocks are rated B (Buy), 41.79% are rated C (Hold), 35.67% are rated D (Sell), and 15.97% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -157.91x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.